ARK Genomic Revolution ETF vs Sprott Uranium Miners ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.61, while Sprott Uranium Miners ETF trades at $55.6. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | URNM | |
|---|---|---|
Sector | Sector/Thematic | Commodities - Metals/Agriculture |
52-Week High | $44.55 | $83.99 |
52-Week Low | $24.02 | $44.14 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
URNM trades at $55.97, up 2.51% today, with a bullish technical signal driven by moving averages. The ETF focuses on uranium miners, benefiting from nuclear energy's resurgence. Recent news highlights significant government funding and AI-driven power demand as catalysts. Key support is at $55, with resistance at $56.
The outlook is positive due to structural uranium supply deficits and growing nuclear adoption, but risks include volatility from spot price swings and concentrated miner exposure. Analyst sentiment is mixed, with some favoring pure-miner exposure while others caution on valuation gaps versus underlying uranium prices.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →